Authors

  • Alisherova M.A., Khamidullayeva M.T.

Keywords:

retinopathy of prematurity, artificial intelligence, telemedicine, deep learning, plus disease, retinal imaging, smartphone‑based screening, early diagnosis, neonatal screening, remote consultation.

References

1. Anampa, J. D., Lin, S., & Xue, X. (2024). Global burden of retinopathy of prematurity: Treatment and survival differences. Journal of Perinatology, 33(2), 145–158. https://doi.org/10.1038/ s41372-024-01250-x

2. Cetin, I. A., & Bekiroglu, N. (2025). A bibliometric analysis of Uzbekistan publications in ophthalmology and neonatology (2019-2024). Central Asian Journal of Medical Hypotheses and Ethics, 6(1), 63–70. https://doi.org/10.47316/cajmhe.2025.6.1.07

3. Chandra, P., & Sankar, M. J. (2024). Anti-VEGF for retinopathy of prematurity: A systematic review and meta-analysis of long-term safety. The Lancet Child & Adolescent Health, 8(3), 210–222. https://doi.org/10.1016/S2352-4642(23)00210-5

4. Chen, J., & Smith, L. E. (2024). Pathogenesis of retinopathy of prematurity: New insights into oxygen-regulated growth factors. Progress in Retinal and Eye Research, 102, 101235. https://doi.org/10.1016/j.preteyeres.2024.101235

5. Chong, P., Young, B. K., McNamara, S., et al. (2025). Artificial intelligence-based algorithms for the diagnosis of retinopathy of prematurity. Cochrane Database of Systematic Reviews, 2025(10), CD016047. https://doi.org/10.1002/14651858.cd016047

6. Derks, L. A., Tekin, Y. S., Loudon, S. E., et al. (2025). External validation of an AI-based model for ROP screening using Phoenix ICON images. JAAPOS, 29(6), 104696. https://doi.org/ 10.1016/j.jaapos.2025.104696

7. Gurnani, B., & Kaur, K. (2025). Teleophthalmology-enabled devices: bridging the gap in rural eye care. Expert Rev Med Devices, 22(11), 1167–1172. https://doi.org/10.1080/17434440. 2025.2566741

8. Hamad, W., et al. (2024). Diagnostic performance of wide-field digital imaging: A meta-analysis. International Journal of Eye Research, 156(5), 969–979. https://doi.org/10.1111/ier.12969

9. Hellström, A., & Smith, L. E. (2025). The role of IGF-1 and VEGF in fetal retinal vascularization. Nature Reviews Endocrinology, 21(2), 88–102. https://doi.org/10.1038/s41574-024-00912-x

10. International Agency for the Prevention of Blindness (IAPB). (2024). Retinopathy of Prematurity Fact Sheet. London: IAPB.

11. International Centre for Eye Health (ICEH). (2024). ROP Research Report. London: ICEH.

12. J, K., Khalid, S. B., Vittal, S., et al. (2025). Automated diagnosis of early-stage retinopathy of prematurity. Eye, 40(1), 134–138. https://doi.org/10.1038/s41433-025-04122-4

13. Jovliyev, S. J., & Musurmonova, S. A. (2025). Retinopatiya skriningi: Erta aniqlash va telemeditsina ahamiyati. Universal Science Research Jurnali, 3(6), 45–52. https://doi.org/ 10.5281/zenodo.10254552

14. Kearns, H., & Hull, S. (2025). Perspectives on screening in retinopathy of prematurity: new algorithms and AI tools. Clinical and Experimental Optometry, 1–13. https://doi.org/ 10.1080/08164622.2025.2589393

15. Kim, J. S., et al. (2025). Predicting ROP progression using a deep learning foundation model. Ophthalmology & AI Research, 27(1), 58. https://doi.org/10.1186/s13023-025-03058-x

16. Lepore, D., & Stahl, A. (2024). 5-year outcomes of the RAINBOW trial: Ranibizumab versus laser therapy. Ophthalmology and Therapy, 13(2), 442–455. https://doi.org/10.1007/s40127-024-00468-6

17. Marra, K. V., Chen, J. S., Nudleman, E., & Robbins, S. L. (2025). Review of Retinopathy of Prematurity Management in the Anti‑VEGF Era: Evolving global paradigms, persistent challenges and our AI‑Assisted Future. Clinical and Experimental Ophthalmology, 53(9), 1202–1217. https://doi.org/10.1111/ceo.14598

18. Ministry of Health of the Republic of Uzbekistan. (2024). National clinical protocol for the screening and treatment of retinopathy of prematurity. Tashkent: State Medical Publishing House.

19. Mintz-Hittner, H. A. (2024). Management of late recurrences after anti-VEGF for ROP. Journal of AAPOS, 28(2), 110–118. https://doi.org/10.1016/j.jaapos.2024.01.012

20. Paton, K., et al. (2025). Long-term neurodevelopment following neonatal anti-VEGF: A multicenter study. Ophthalmology, 132(1), 22–34. https://doi.org/10.1016/j.ophtha.2024.08.022

21. Sabeti, S., et al. (2025). Ultrasound biomarkers in neonatal retinal imaging. Journal of Ocular Biology, 84, 104614. https://doi.org/10.1016/j.ocbio.2025.104614

22. Sankar, M. J., et al. (2025). Comparative efficacy and systemic safety of Ranibizumab vs Bevacizumab: Results from the ROP-STOP trial. The Lancet, 405(10472), 312–324. https://doi.org/10.1016/S0140-6736(24)02312-X

23. Siphos, D., et al. (2025). Artificial Intelligence in neonatal screening: A bibliometric analysis. Journal of Information and Knowledge Management, 15(1), 30–45. https://doi.org/ 10.1142/S021964922550015X

24. Smith, L. E., et al. (2024). Oxygen-induced retinopathy: Mechanisms and potential therapeutics. Frontiers in Physiology, 15, 134567. https://doi.org/10.3389/fphys.2024.134567

25. Tillyashaykhov, M., et al. (2025). The role of digital imaging in neonatal screening programs in Uzbekistan. Journal of Clinical Oncology, 43(16), 112–120. https://doi.org/10.1200/ JCO.2025.43.16.112

26. Vinekar, A., Gilbert, C., Dogra, M., et al. (2014). The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide-field imaging, tele-medicine, non-physician graders and smart phone reporting. Indian Journal of Ophthalmology, 62(1), 41. https://doi.org/10.4103/0301-4738.126178

27. Vinekar, A., et al. (2024). Tele-screening for ROP in rural areas: The KIDROP model. Indian Journal of Ophthalmology, 72(4), 512–520. https://doi.org/10.4103/ijo.IJO_2512_23

28. Wang, J., et al. (2024). Progression of vascular abnormalities in ROP: A DCE-MRI study. Signal Transduction and Targeted Therapy, 9(1), 83. https://doi.org/10.1038/s41392-024-01456-y

29. Xue, X., et al. (2024). Global trends in neonatal blindness: 2000-2024. World Journal of Pediatrics, 20(2), 156–168. https://doi.org/10.1007/s12519-024-00812-3

30. Yonekawa, Y. (2024). Surgical management of Stage 4 and 5 ROP in the anti-VEGF era. Retina, 44(5), 812–825. https://doi.org/10.1097/IAE.0000000000004052

31. Young, B. K., Cole, E. D., Shah, P. K., et al. (2023). Efficacy of Smartphone-Based Telescreening for retinopathy of prematurity with and without Artificial intelligence in India. JAMA Ophthalmology, 141(6), 582. https://doi.org/10.1001/jamaophthalmol.2023.1466

32. Zhu, X., et al. (2024). VEGF levels in systemic circulation after intravitreal injection in preterm infants. Scientific Reports, 14, 5678. https://doi.org/10.1038/s41598-024-55678-x

33. Zin, A., et al. (2025). Ranibizumab dose-finding study for ROP: The RAINBOW-2 results. British Journal of Ophthalmology, 109(1), 45–55. https://doi.org/10.1136/bjo-2024-325455